Sun Pharma’s Organon buy took shape over three months of intense negotiations

“Today, Organon is not an investable company, but with Sun Pharma acquiring it, the company will become an investable company. This means Organon’s existing bondholders will be happy to swap their bonds from the target to Sun,” the banker said.